–
Vistagen Therapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
millions USD
FY22:
FY23:
–
FY24:
–
FY25:
–
FY26:
–
(positive)
Change from FY22 to FY26
millions USD
FY22:
−47.8
FY23:
−59.3
FY24:
−33.0
FY25:
−56.0
FY26:
−72.1
(positive)
Change from FY24 to FY26
millions USD
FY22:
–
FY23:
–
FY24:
−32.5
FY25:
−55.3
FY26:
−71.4
(positive)
Change from FY22 to FY26
millions USD
FY22:
−47.8
FY23:
−59.2
FY24:
−29.4
FY25:
−51.4
FY26:
−69.7
(positive)
Change from FY22 to FY26
millions USD
FY22:
−47.8
FY23:
−59.2
FY24:
−29.4
FY25:
−51.4
FY26:
−69.7
All amounts in millions USD